Clinical trial
A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.
NCT00758420 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- August 31, 2009
- Enrollment
- 77 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.